SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001723128-19-000140
Filing Date
2019-12-16
Accepted
2019-12-16 17:52:17
Documents
2
Period of Report
2019-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_157653671955474.html 3  
1 FORM 3 wf-form3_157653671955474.xml 3 1723
2 GEORGE POA georgepoa1.htm EX-24 8371
  Complete submission text file 0001723128-19-000140.txt   11479
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
George Jeffrey P. (Reporting) CIK: 0001796789 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38485 | Film No.: 191288204